1,520 Alzheimers Headlines
Patricio Reyes M.D., F.A.N.N.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

Barrow Neurological Institute
St. Joseph's Hospital and Medical Center
"2 NEW THERAPIES FOR ALZHEIMER'S"
Produced by MD Health Channel
Executive Editor.....Anne-Merete Robbs
CEO..............Stan Swartz

Dr. Reyes and his team are constantly working on new medicines and new solutions...You will receive news alerts...information on new trials as Dr Reyes announces them!
"2 NEW THERAPIES FOR ALZHEIMER'S"
Patricio Reyes M.D., F.A.N.N.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

St. Joseph's Hospital and Medical Center



DO YOU HAVE ALZHEIMERS?
 
"HELP DR. REYES... IN HIS BATTLE TO FIND A CURE...
.HE NEEDS YOUR HELP:
YOU CAN HELP WIN THE BATTLE FOR A CURE BY JOINING A TRIAL!!"....

Stan Swartz, CEO,
The MD Health Channel



"You'll receive all medication and study based procedures at
no charge

if you qualify for one of the many trials being conducted at Barrow Neurological Institute."
 

"Dr. Reyes Changed My Life"

- John Swartz
92 Years Old
Attorney at Law
"Dr.Reyes Changed My Life "
1:18
"At 92...I had lost my will to live"
5:48
Tips on Aging
2:29
"Dr. Reyes gave me customized health care"
2:09

Patricio Reyes M.D.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

Barrow Neurological Institute

St. Joseph's Hospital and Medical Center
"PRESERVING BRAIN FUNCTIONS "
Runtime: 50:22
Runtime: 50:22
"2 NEW THERAPIES FOR ALZHEIMER'S"
Runtime: 10:27
Runtime: 10:27
ALZHEIMER'S AWARENESS PROGRAMS
Runtime: 5:00
Runtime: 5:00
BIOMEDICAL RESEARCH IN ALZHEIMER'S DISEASE
PDF Document 850 kb

Download Free

4 TALES OF NEUROSURGERY &
A PIANO CONCERT BY DR. SPETZLER...
Plus 2 books written by Survivors for Survivors!
Robert F. Spetzler M.D.
Director, Barrow Neurological Institute

J.N. Harber Chairman of Neurological Surgery

Professor Section of Neurosurgery
University of Arizona
TALES OF NEUROSURGERY:
A pregnant mother..a baby..faith of a husband.. .plus... Cardiac Standstill: cooling the patient to 15 degrees Centigrade!
Lou Grubb Anurism
The young Heros - kids who are confronted with significant medical problems!
2 Patients...confronted with enormous decisions before their surgery...wrote these books to help others!
A 1 MINUTE PIANO CONCERT BY DR. SPETZLER

Michele M. Grigaitis MS, NP
Alzheimer's Disease and Cognitive Disorders Clinic

Barrow Neurological Clinics
COPING WITH DEMENTIA
 
Free Windows Media Player Click

Links
Barrow Neurological Institute

Archives
October 2006  
November 2006  
December 2006  
January 2007  
February 2007  
March 2007  
May 2007  
June 2007  
November 2007  
December 2007  
April 2008  
July 2008  
August 2008  
September 2008  
October 2008  
November 2008  
December 2008  
January 2009  
February 2009  
March 2009  
April 2009  
May 2009  
February 2010  
March 2013  
May 2013  
November 2013  
January 2014  
February 2014  
March 2014  
April 2014  
May 2014  
June 2014  
July 2014  
June 2016  
July 2016  
August 2016  
September 2016  
October 2016  
November 2016  
December 2016  
January 2017  
February 2017  
March 2017  
April 2017  
May 2017  
June 2017  
July 2017  
August 2017  
September 2017  
October 2017  
November 2017  
December 2017  
January 2018  
February 2018  
March 2018  
April 2018  
May 2018  
June 2018  
July 2018  
August 2018  
September 2018  
October 2018  

This page is powered by Blogger. Isn't yours?

Thursday, August 4, 2016

 

Alzheimer's: Biochip blood test detects disease risk




























Biochip blood testing for Alzheimer's disease risk provides a faster alternative to standard testing

Researchers have developed a faster, more affordable method of identifying patients more susceptible to Alzheimer's disease using a biochip-based blood test, with the same accuracy as a standard DNA test.

Standard molecular tests that analyze DNA can be both expensive and time-consuming. However, the biochip test, produced by Randox Laboratories, can conduct multiple tests on a single blood sample, which has both time- and cost-saving benefits, as well as a rapid diagnosis.

The apolipoprotein E (APOE) gene plays a key role in lipid metabolism and is recognized as one of the most significant genetic risk factors for dementia and other neurodegenerative diseases.

There are three versions of the APOE gene: e2, e3, and e4. The e4 version increases a person's risk of developing late-onset Alzheimer's disease, and it may also be associated with an earlier onset of memory loss.

Alzheimer's is a type of dementia that causes problems with memory, thinking, and behavior. Symptoms develop slowly and get worse over time, becoming severe enough to interfere with daily tasks.

One APOE gene is inherited from each parent. If a person inherits one APOE variant from a parent, they have a three times greater risk of developing Alzheimer's disease. A person who inherits APOE variants from both parents is 8-12 times more likely to develop the disease.

Around 25 percent of the population inherits one copy of the APOE e4 gene. Inheriting two copies increases a person's disease risk by 10 times or more.

The biochip blood test accurately detects an individual's APOE4 status from a plasma sample, which - in combination with medical and family history, medication, and lifestyle - can help offer information, advice, and personalized medicine for the patient.

"This is the first time that we have used this biochip technology to test for an increased risk of Alzheimer's disease," says Emma C. Harte, Ph.D., a research scientist at Randox Laboratories. "This type of testing is important in our quest to understand and diagnose Alzheimer's and empower patients to understand risks, consider medication, and even make early lifestyle changes."

Biochip and standard molecular diagnostic test results exactly the same
The research, presented at the 68th AACC Annual Scientific Meeting & Clinical Lab Expo in Philadelphia, verified the accuracy of the biochip blood test by analyzing 384 samples and comparing the results to that of a standard molecular diagnostic test.

With colleagues at the Medical University of Vienna, Austria, Randox Laboratories found that on comparing the results of the two tests, they were in 100 percent agreement.

Biochip tests allow clinicians and researchers to gain results in 3 hours, enabling doctors to assess quickly the risk of an individual developing Alzheimer's disease.

Story Source: The above story is based on materials provided by MEDICALNEWSTODAY
Note: Materials may be edited for content and length